Discovery of Plasma Lipids as Potential Biomarkers Distinguishing Breast Cancer Patients from Healthy Controls
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111559 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Desmond Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: BCAL Diagnostics Ltd., Sydney, NSW 2000, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, Lipids. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
The development of a sensitive and specific blood test for the early detection of breast cancer is crucial to improve screening and patient outcomes. Existing methods, such as mammography, have limitations, necessitating the exploration of alternative approaches, including circulating factors. Using 598 prospectively collected blood samples, a multivariate plasma-derived lipid biomarker signature was developed that can distinguish healthy control individuals from those with breast cancer. Liquid chromatography with high-resolution and tandem mass spectrometry (LC-MS/MS) was employed to identify lipids for both extracellular vesicle-derived and plasma-derived signatures. For each dataset, we identified a signature of 20 lipids using a robust, statistically rigorous feature selection algorithm based on random forest feature importance applied to cross-validated training samples. Using an ensemble of machine learning models, the plasma 20-lipid signature generated an area under the curve (AUC) of 0.95, sensitivity of 0.91, and specificity of 0.79. The results from this study indicate that lipids extracted from plasma can be used as target analytes in the development of assays to detect the presence of early-stage breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BCAL Diagnostics Ltd., Sydney, NSW 2000, Australia.
- OmniOmics.ai Pty Ltd., Pagewood, NSW 2035, Australia.
- InsightStats, Croydon Park, NSW 2133, Australia.
- Department of Surgery, The Royal Melbourne Hospital, Parkville, VIC 3050, Australia.
- The Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3010, Australia.
- BreastScreen Victoria, Carlton, VIC 3053, Australia.
ORCID-Profile: Amani Batarseh
Zitieren
APA
Li, D., Heffernan, K., Koch, F. C., Peake, D. A., Pascovici, D., David, M., Kehelpannala, C., Mann, G. B., Speakman, D., Hurrell, J., Preston, S., Vafaee, F., & Batarseh, A. (2024). Discovery of Plasma Lipids as Potential Biomarkers Distinguishing Breast Cancer Patients from Healthy Controls. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111559
Vancouver
Li D, Heffernan K, Koch FC, Peake DA, Pascovici D, David M, et al. Discovery of Plasma Lipids as Potential Biomarkers Distinguishing Breast Cancer Patients from Healthy Controls. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111559
BibTeX
@article{Li2024,
author = {Li, Desmond and Heffernan, Kerry and Koch, Forrest C and Peake, David A and Pascovici, Dana and David, Mark and Kehelpannala, Cheka and Mann, G Bruce and Speakman, David and Hurrell, John and Preston, Simon and Vafaee, Fatemeh and Batarseh, Amani},
title = {Discovery of Plasma Lipids as Potential Biomarkers Distinguishing Breast Cancer Patients from Healthy Controls},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111559}
}
EUVIMED